NATTOKINASE

Nattokinase is a serine protease derived from fermented soybeans that promotes fibrinolysis by enhancing plasmin generation and degrading fibrin. It is used as a nutraceutical for cardiovascular support. Benefits include improved circulation and potential thrombosis prevention. Side effects include an increased bleeding tendency, hypotension, and interactions with anticoagulant or antiplatelet drugs. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 7842d9245ac1 Category: Tag:

Product Description


Mechanism of Action

NATTOKINASE exhibits a multivector biochemical action pattern, influencing enzymatic cascades, receptormediated signalling, intracellular ion behaviour, mitochondrial oxidative dynamics and transcriptional regulatory networks. Its structural characteristics suggest interaction with catalytic residues, allosteric pockets and regulatory scaffolds, enabling modulation of phosphorylation circuits, secondmessenger systems (cAMP, Ca²⁺, IP), ROS generation, membrane polarization and metabolicflux channeling.

Depending on biological context, NATTOKINASE may alter mitochondrial membrane potential, redox buffering capacity, calcium sequestration, cytoskeletal integrity, vesicle trafficking efficiency and transcriptionfactor activation, resulting in broad mechanistic adaptability across experimental systems.

Benefits and Advantages

This compound is highly valued in advanced biochemical and pharmacological research frameworks, including:

  • Highresolution receptorligand mapping and affinity prediction
  • Enzymekinetic profiling and catalyticpathway deconstruction
  • Mitochondrialstress testing, ATPflux analysis and ROSequilibrium studies
  • Integrated multiomics research: transcriptomics, metabolomics, proteomics, phosphoproteomics
  • Cytoskeletal modelling involving actin/tubulin regulation
  • Apoptosis, autophagy, necroptosis and ferroptosis signalling investigations
  • Structureactivity relationship (SAR) exploration and molecular optimisation
  • Pharmacodynamic simulations for mechanistic threshold and doseresponse studies

Side Effects and Risks

Possible laboratoryobserved risks include:

  • Redox imbalance with elevated ROS levels
  • Mitochondrial overactivation or respiratorychain suppression
  • Ionchannel dysregulation affecting Na⁺/K⁺/Ca²⁺ flow
  • Crossactivation or inhibition of unintended receptor systems
  • Cytoskeletal destabilisation and impaired membrane integrity
  • Dosedependent cytotoxicity or induction of apoptotic/autophagic pathways
  • Transcriptional instability and activation of inflammatory cascades (NF-κB, JNK, p38)

Strict biosafety handling, controlled dosing and regulated environmental conditions are required for all experimental use. Not intended for human or veterinary application.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

Protein

Molecular Weight

27500.0 g/mol

CAS Number

133876-92-3

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

1201902-80-8; MLN9708; MLN-9708; MLN 9708; DTXSID10152721

IUPAC/Chemical Name

Protease enzyme complex

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download